Press Releases
Page 2 of 26
Onxeo offre 10,7% de son capital à Invus – Biotech Finances
(French only) Regards croisés : Interviews of Judith Greciet, CEO of Onxeo, and Mr Nicolas Trebouta, representing Financière de la […]
Tags: Financials & Corporate
06/15/2020
BFM Business Intégrale Bourse : Onxeo, Company of the Day
Interview of Judith Greciet, CEO of Onxeo, following the entry into the capital of Invus, a long-term renowned investor […]
Tags: AsiDNA™, Financials & Corporate
06/10/2020
Onxeo announces a capital increase of €7.3 million by private placement to Invus and Financière de la Montagne, the Company’s historical shareholder
The funds raised will accelerate the development of Onxeo’s programs, and extend its cash runway into Q1 2022 Paris […]
Tags: Financials & Corporate
06/09/2020
Onxeo announces that the Shareholders’ Meeting of May 29, 2020 has approved all ordinary resolutions
The Extraordinary General Meeting will be held on June 19, 2020 on the second call Paris (France), May 29, […]
Tags: Financials & Corporate
05/29/2020
Onxeo Announces Approval of the REVocan Study By Regulatory Authorities
The REVocan study aims to evaluate the abrogation by AsiDNA™ of tumor resistance to a PARP inhibitor in relapsed ovarian […]
Tags: AsiDNA™
Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation
Paris (France), May 27, 2020 – 8.45 am CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]
Tags: Financials & Corporate
05/27/2020
Onxeo to Present New Preclinical Data at AACR 2020 Confirming the Ability of AsiDNA™ to Reverse Cancer Resistance to PARPi
Paris (France), Mai 19, 2020 – 5.45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]
Tags: AsiDNA™
05/19/2020
Onxeo’s Joint General Meeting in camera on May 29, 2020: availability of preparatory documents and live webcast login information
Paris (France), May 7, 2020 – 7:30 a.m. CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo”, […]
Tags: Financials & Corporate, General meetings
05/07/2020
Publication of the 2019 Universal Registration Document
Paris (France), April 27, 2020 – 7.00 p.m. CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo”, […]
Tags: Financials & Corporate
04/27/2020
Onxeo Reports Full-Year 2019 Financial Results and Provides Business Update
Cash position of €5.7 million at December 31, 2019, combined with $6.6 million from new agreement with Acrotech, provide extended […]
Tags: belinostat / Beleodaq
04/17/2020
Page 2 of 26